Larotrectinib (Vitrakvi,Larodx)

Larotrectinib is the world’s first highly selective neurotrophic tyrosine receptor kinase (TRK) inhibitor and a tissue-agnostic precision targeted antineoplastic agent.

25mg*60capsules
100mg*60capsules

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.

Authentic

Guarantee

Fast Delivery

Privacy

Larotrectinib Medication Guide

Larotrectinib Dosage Guidelines

Larotrectinib, a precision-targeted therapy against NTRK gene fusions, requires individualized dosage and administration based on the patient's tu···【More】
Update: 25 Mar,2026Source: BigbearViews: 91
Is Larotrectinib a Targeted Therapy or an Immunotherapy

Classification of LarotrectinibLarotrectinib is a targeted therapeutic agent belonging to the class of TRK inhibitors.It acts by selectively inhibitin···【More】
Update: 11 Mar,2026Source: BigbearViews: 96